Abhi Bhat, PhD

Abhi has over 20 years of broad cross functional drug discovery experience spanning bio-conjugates, small molecules, and peptides across multiple therapeutic areas. Most recently, Abhi was the Sr. VP and Head of R&D at Design Therapeutics where he oversaw medicinal chemistry, biology, CMC and formulation functions and delivered the lead clinical asset for treatment of Friedrich ataxia along with a preclinical pipeline of GeneTACâ„¢ molecules for treating nucleotide repeat disorders.   Abhi was previously the CSO at Pyramid Biosciences where he oversaw the development of two distinct Trk-Kinase inhibitors currently in clinical development for oncology and dermatology indications.  Prior to Pyramid, Abhi held R&D leadership roles at Ipsen, Redwood, Pfizer and CovX where he led projects from concept validation through early clinical development in oncology, metabolic diseases, pain and inflammation. Abhi received his PhD from The Ohio State University and conducted postdoctoral research at the Univ. of Arizona.